TD Cowen reiterates Buy rating on Eli Lilly, $1250 target
TD Cowen reiterated a Buy rating on Eli Lilly with a $1250 price target, implying 7.3% upside versus the Sep 21 close of $1164.89.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.